Skip to main content

Join Binding Site at ASH 2026: Advancing Multiple Myeloma Diagnostics with Mass Spectrometry


Date: Dec 12–14, 2026 Location: Ernest N. Morial Convention Center, New Orleans, Louisiana Booth number: 2212

About ASH

This December, the Binding Site team will join leading innovators, researchers, and clinicians from around the world at the 2026 American Society of Hematology (ASH) Annual Meeting.

With hundreds of sessions and thousands of abstracts, the ASH annual meeting is the largest hematology conference where the latest clinical advances from around the world are shared.

Why do we attend ASH?

At Binding Site, part of Thermo Fisher Scientific, we are committed to improving patient lives through innovation. Attending ASH enables us to stay up to date with the latest research in Multiple Myeloma and related disorders, and share key information about our portfolio with like-minded experts.

Our recent contribution to Myeloma diagnostics

In 2025, we announced in this press release that Binding Site has received 510(k) clearance for the EXENT™ System to aid in the diagnosis of Multiple Myeloma. 

Our team will be at ASH to answer any questions you may have on our innovative automated mass spectrometry solution.

Image of the EXENT System

Talk to us about

 

EXENT System

A breakthrough in monoclonal​ gammopathy assessment

Multiple Myeloma

Symptoms, manifestations and complications

Monoclonal Gammopathy of Undetermined Significance (MGUS)

Signs, symptoms, diagnosis and monitoring

Meet the team

Resources

New perspectives on monoclonal proteins: Advancing diagnostic confidence with the EXENT System

Case study: New perspectives on monoclonal proteins

Learn how the EXENT GAM Assay can offer insights into M-protein light chain glycosylation which has been described in the literature as a potent risk factor for progression to malignant plasma cell disorders.

Connect with our experts

Complete the form below and we will be in touch to arrange a meeting

*Fields marked with an asterisk are required.

*The EXENT™ System combines EXENT™ Analyser with the Immunoglobulin Isotypes (GAM) for the EXENT™ Analyser.

EXENT is a registered trademarks of The Binding Site Group Ltd (Birmingham, UK) in certain countries

© 2026 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific or its subsidiaries.

Product availability is subject to country specific regulatory requirements.

Contact your local representative for availability in your country.